Page last updated: 2024-10-22

amitriptyline and Libman-Sacks Disease

amitriptyline has been researched along with Libman-Sacks Disease in 3 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dove, FB1
Tilz, GP1
Teubl, I1
Kopplhuber, C1
Vollmann, H1
Lanzer, G1
Chiu, E1

Other Studies

3 other studies available for amitriptyline and Libman-Sacks Disease

ArticleYear
Drug-induced lupus.
    Hospital practice (Office ed.), 1993, Aug-15, Volume: 28, Issue:8

    Topics: Amitriptyline; Humans; Lupus Erythematosus, Systemic

1993
[Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Medizinische Klinik, 1976, Nov-05, Volume: 71, Issue:45

    Topics: Adult; Amitriptyline; Antilymphocyte Serum; Bone Neoplasms; Female; Hemophilia A; Humans; Hyperthyro

1976
Psychiatric aspects of disseminated lupus erythematosus in Hong Kong Chinese--report of three cases.
    The Australian and New Zealand journal of psychiatry, 1971, Volume: 5, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Amitriptyline; Chlorpromazine; Epilepsy

1971